ALAN HARVEY MAURER
Medical Practice in Penn Wynne, PA
License number
Pennsylvania MD018608E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Penn Wynne, PA 19096
Personal information
See more information about ALAN HARVEY MAURER at radaris.comName
Address
Phone
935 Boswell Heights Dr #935, Boswell, PA 15531
935 Boswell Heights Dr, Boswell, PA 15531
1384 Pottsville St, Lykens, PA 17048
1384 Pottsville St, Wiconisco, PA 17097
1705 Warpath Rd, West Chester, PA 19382
Professional information
Enhancement Of Nmr Imaging Of Tissue By Paramagnetic Pyrophosphate Contrast Agent
US Patent:
4867963, Sep 19, 1989
Filed:
Jan 29, 1987
Appl. No.:
3/470086
Inventors:
Alan H. Maurer - Wynnewood PA
Linda C. Knight - East Windsor NJ
Jeffrey A. Siegel - Voorhees NJ
Linda C. Knight - East Windsor NJ
Jeffrey A. Siegel - Voorhees NJ
Assignee:
Temple University of the Commonwealth System of Higher Education - Philadelphia PA
International Classification:
A61K 4900
US Classification:
424 9
Abstract:
Nuclear magnetic resonance imaging of animal or human tissue is enhanced when a paramagnetic pyrophosphate compound is administered intraveneously as a contrast agent. The contrast agent is particularly useful in magnetic resonance imaging of area of tissue calcification, such as acute myocardial infarctions. Specific localization of paramagnetic pyrophosphate in ischemic and necrotic muscle cells at the periphery of a myocardial infarction makes accurate localization and sizing of the central infarct and peri-infarct zones possible.
Thrombus Detection Using Radiolabelled Disintegrins
US Patent:
5380646, Jan 10, 1995
Filed:
Oct 19, 1992
Appl. No.:
7/965674
Inventors:
Linda C. Knight - Moorestown NJ
Alan H. Maurer - Wynnewood PA
Alan H. Maurer - Wynnewood PA
Assignee:
Temple University of the Commonwealth System of Higher Education - Philadelphia PA
International Classification:
A61K 4902, G01N 3353
US Classification:
424 169
Abstract:
Radiolabelled polypeptides derived from the Viperidae disintegrins are provided as well as a method for the detection of venous and arterial thrombi, pulmonary emboli and tumors or abscesses that have a thrombus component. Compositions suitable for parenteral administration comprising the radiolabelled polypeptides and a pharmaceutically acceptable carrier are also provided.